Effects of rosiglitazone on fasting plasma fibroblast growth factor-21 levels in patients with type 2 diabetes mellitus.

Keywords

Rosiglitazone, Internal medicine, Endocrinology, Medicine, Metformin

References

• The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.Cecilia Gälman, Tomas Lundåsen, Alexei Kharitonenkov — 2008
• Identification of a novel FGF, FGF-21, preferentially expressed in the liver.Tetsuya Nishimura, Yuhki Nakatake, Morichika Konishi — 2000
• FGF-21 as a novel metabolic regulator.Alexei Kharitonenkov, Tatiyana L. Shiyanova, Anja Köester — 2005
• Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.W.-W. Chen, L. Li, G.-Y. Yang — 2007
• Plasma FGF-21 levels in type 2 diabetic patients with ketosis.Ling Li, Gangyi Yang, Heu Ning — 2008
• Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signalingJulie S. Moyers, Tatiyana L. Shiyanova, Farrokh Mehrbod — 2007
• Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.W. Timothy Garvey, Lidia Maianu, T P Huecksteadt — 1991
• The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes.Adam B. Mayerson, Ripudaman S. Hundal, Sylvie Dufour — 2002
• betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.Masashi Suzuki, Yuriko Uehara, Kaori Motomura-Matsuzaka — 2008
• The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.Alexei Kharitonenkov, Victor J. Wroblewski, Anja Köester — 2007
• Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.Theodore P. Ciaraldi, Alice P.S. Kong, Neelima V. Chu — 2002
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationK. G. M. M. Alberti, Paul Zimmet, WHO Consultation — 1998
• Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor γ and Altered Metabolic StatesEric S. Muise, B. Azzolina, David W. Kuo — 2008
• Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in HumansXinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek — 2008
• FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlothoAlexei Kharitonenkov, James D. Dunbar, Holly A. Bina — 2008
• Identification of a Domain within Peroxisome Proliferator-Activated Receptor γ Regulating Expression of a Group of Genes Containing Fibroblast Growth Factor 21 That Are Selectively Repressed by SIRT1 in AdipocytesHong Wang, Li Qiang, Stephen R. Farmer — 2007

Cited by

• The effectiveness of different lifestyle interventions onbody composition, insulin sensitivity, and novelbiomarkers of insulin resistance in obese individualsDiane Cooper — 2014
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.Shelley R. Salpeter, Elizabeth Greyber, Gary A Pasternak — 2010
• Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus.Mei Zhang, Ying Liu, Zhong-yun Xiong — 2013
• Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical TrialYu Qin, Yong Zhou, Shihui Chen — 2015
• Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin ResistanceMengliu Yang, Lili Zhang, Chong Wang — 2012
• Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation.Yin-Hang Yu, Fuliang Bai, Wenfei Wang — 2015
• Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones.Andrew C. Adams, Tamer Coşkun, Christine C. Cheng — 2013
• Fibroblast Growth Factor-21 Regulates PPARγ Activity and the Antidiabetic Actions of ThiazolidinedionesPaul A. Dutchak, Takeshi Katafuchi, Angie L. Bookout — 2012
• The effects of fibroblast growth factor-21 knockdown and over-expression on its signaling pathway and glucose-lipid metabolism in vitro.Ké Li, Ling Li, Mengliu Yang — 2012
• Effects of Short-Term Continuous Subcutaneous Insulin Infusion on Fasting Plasma Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes MellitusMengliu Yang, Jing Dong, Hua Liu — 2011
• Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesityFredirick Mashili, Reginald L. Austin, Atul S. Deshmukh — 2011
• Silencing of FGF‐21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3–SOCS3 signalCong Wang, Jihuan Dai, Mengliu Yang — 2014
• The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy.Jia Liu, Yuan Xu, Yanjin Hu — 2015
• Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectivesYu Cho Woo, Aimin Xu, Yu Wang — 2013
• Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational DiabetesBee K. Tan, Kavitha Sivakumar, Muhammad Furqan Bari — 2013
• Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal FluidBee K. Tan, Manfred Hallschmid, Raghu Adya — 2011
• Rosiglitazone inhibits expression and secretion of PEDF in adipose tissue and liver of male SD rats via a PPAR-γ independent mechanism.Shumin Yang, Ting Luo, Huang Zhou — 2014
• Ingestion of eicosapentaenoic acid in the early stage of social isolation reduces a fibroblast growth factor 21 resistant state independently of body weight in KKA(y) mice.Katsunori Nonogaki, Tomoe Yamazaki, Mari Murakami — 2015
• Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 DiabetesHui Fan, Xiaomeng Sun, Heng Zhang — 2016
• MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21Pedro Iglesias, Rafael Selgas, Sara Romero — 2012

Related papers

• Rosiglitazone and Cardiovascular Risk – A ReviewS. Isa — 2012
• Rosiglitazone compound formula eliminates the side effects of rosiglitazoneWang Li-l — 2014
• The progress of clinical study on rosiglitazoneXin Jia — 2003
• FDA Lifts Restrictions on RosiglitazoneDiane S. Aschenbrenner — 2014
• Re-evaluation of the cardiovascular safety of rosiglitazoneYanming Chen, Longyi Zeng — 2014
• The evaluation of therapeutic effect and safety of rosiglitazone combined with metformin on incipient type 2 diabetesLI Guo-hu — 2010
• Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndromeLiao, Lin, Tian — 2011
• Metformin and insulin sensitizerrosiglitazone combination in improving nonalcoholic fatty liver diseaseYE Qiu-tao — 2012
• Rosiglitazone/MetforminKeri Wellington — 2012
• Metformin as secondary therapy in a defined population with type 2 diabetes.Jonathan B. Brown, Kathryn L. Pedula — 1999